Related Experiment Video
Updated: Nov 1, 2025
A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
Published on: April 27, 2019
Prognostic value of cardiopulmonary exercise test after heart transplantation
Diego Iglesias1, Walter Masson1, Leandro Barbagelata1
1Cardiology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Insights
Cardiopulmonary exercise testing (CPET) can predict hospitalizations in heart transplant (HTX) recipients. Key indicators like peak VO2 and oxygen pulse are independently associated with reduced hospitalizations post-transplant.
Area of Science:
- Cardiology
- Transplant Medicine
- Exercise Physiology
Background:
- Clinical utility of cardiopulmonary exercise testing (CPET) in heart transplantation (HTX) patients remains understudied.
- Assessing post-transplant outcomes is crucial for managing HTX recipients.
Purpose of the Study:
- To determine the predictive value of CPET for hospitalizations and mortality in HTX recipients.
- To identify specific CPET parameters associated with adverse events after heart transplantation.
Main Methods:
- Retrospective cohort study utilizing a secondary database.
- Included 122 adult HTX recipients who underwent CPET 3-12 months post-transplant.
- Cox proportional hazards regression analyzed time to first HTX-related hospitalization.
Main Results:
- Fifty-seven percent of patients experienced the primary endpoint (HTX-related hospitalization).
- Peak VO2, oxygen pulse, and predicted VO2 were significantly associated with hospitalizations.
- No significant association found between other variables and the outcome.
Conclusions:
- Peak VO2, oxygen pulse, and predicted VO2 are independent predictors of hospitalization in HTX recipients.
- CPET provides valuable prognostic information for heart transplant patients.
- These findings support the integration of CPET into routine post-HTX follow-up.
Background:
The clinical utility of cardiopulmonary exercise testing (CPET) has not been extensively studied yet in heart transplantation (HTX) patients.
Objective:
To analyze the predictive value of the CPET on hospitalizations and mortality in HTX recipients.
Methods:
A retrospective cohort was performed from a secondary database. Patients > 18 years with HTX who underwent a CPET between 3 and 12 months after transplantation were included. Time to the first primary endpoint (HTX-related hospitalization) was analyzed and adjusted using Cox proportional hazards regression model.
Results:
A total of 122 patients (mean age 50.1 years, 77.0% men) were included. Fifty-seven patients (46.7%) had the primary endpoint. Peak VO2 (HR .95; CI 95% .90-.99, P = .03), oxygen pulse (HR .57; CI 95% .34-.96, P = .03) and predicted VO2 (HR .97; CI 95% .96-.99, P = .002) were associated with the endpoint. We did not find a significant association between the other variables and the outcome.
Conclusion:
In HTX recipients, peak VO2 , oxygen pulse, and predicted VO2 were independently associated with hospitalizations at follow up.
